Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 3Overweight 2Obesity 2Colorectal Neoplasms 2Weight Loss 1Ovarian Neoplasms 1Motor Activity 1Metastatic Pancreatic Adenocarcinoma 1Lung Neoplasms 1Leukemia 1Intermittent Fasting 1Hematopoietic and Lymphoid System Neoplasm 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Feeding Behavior 1Fasting 1Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 34Cisplatin 25Blood Specimen Collection 25durvalumab 17Paclitaxel 16osimertinib 15Radiotherapy 15Radiosurgery 15Bevacizumab 15Gemcitabine 14atezolizumab 13Nivolumab 13Biopsy 13Drug Therapy 12Standard of Care 10Practice Guidelines as Topic 10Immunoglobulin G 10Docetaxel 10130-nm albumin-bound paclitaxel 10X-Rays 9Taxes 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Counseling × Clear all
NCT05679349 2026-05-29

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Thomas Jefferson University

Phase NA Recruiting
822 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡